You can see a full list here , but in our experience, the most common complaints include: Nausea, occasionally leading to periods of vomiting Diarrhea and/or constipation Fatigue Bloating/gas Because these medications require titration (i.e
If this trial is succesful, then this could put Rybelsus on par with other GLP1 class drugs in terms of major adverse cardiovascular events (MACE) and further boost sales of Rybelsus in the decade ahead
Organ and tissue growth concerns Because IGF-1 signaling affects cellular growth and proliferation throughout the body and not exclusively in skeletal muscle, there is concern that long-term use of IGF-1 could result in increased growth of other tissues/organs in the body
Additionally, like all health-related content on this website, this guide was thoroughly vetted by one or more members of our Medical Review Board for accuracy, and our editorial team will continue to monitor it for updates
Clinical Context & Research Overview Important: Peptide therapy for performance and sleep support should be discussed with a licensed clinician